Clinical trial
Recombinant Human Leptin Therapy Effects on Insulin Action
NCT01207934
Study timeline
Study start (unknown)1998-08-01Date precision: month
Registry last updated2015-07-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type Two Diabetes Mellitusunresolved
Interventions
Sponsors & collaborators
Washington University School of Medicinelead sponsor
Amgencollaborator
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01207934 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.